Literature DB >> 25755978

Comparative evaluation of humic substances in oral drug delivery.

Mohd Aamir Mirza1, Niyaz Ahmad1, Suraj Prakash Agarwal1, Danish Mahmood2, M Khalid Anwer3, Z Iqbal1.   

Abstract

Major and biologically most explored components of natural organic matter (NOM) are humic acid (HA) and fulvic acid (FA). We have explored rock shilajit as a source of NOM. On the other hand carbamazepine (CBZ) is a well known anticonvulsant drug and has a limited accessibility to brain. Bioavailability and pharmacokinetic profiles of CBZ have been improved by complexation and different techniques also. Present study has assessed the comparative abilities of FA and HA as complexing agent for CBZ in order to enhance pharmacokinetic profile of CBZ and accessibility to the brain. These two complexing agents have been compared on various indices such as their abilities to cause complexation and enhance solubility, permeability and dissolution. The present study also compared pharmacodynamic and biochemical profiles after oral administration of complexes. With the help of various pharmaceutical techniques such as freeze drying, physical mixture, kneading and solvent evaporation, two molar ratios (1:1 and 1:2) were selected for complexation and evaluated for conformational analysis (molecular modeling). Complex formed was further characterized by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR), mass spectroscopy and X-ray diffraction (XRD). Preclinical study on rodents with CBZ-HA and CBZ-FA has yielded appreciable results in terms of their anticonvulsant and antioxidants activities. However, CBZ-HA (1:2) demonstrated better result than any other complex.

Entities:  

Keywords:  Carbamazepine and brain permeability; Fulvic acid; Humic acid; Shilajit

Year:  2011        PMID: 25755978      PMCID: PMC4210272          DOI: 10.1016/j.rinphs.2011.06.001

Source DB:  PubMed          Journal:  Results Pharma Sci        ISSN: 2211-2863


  20 in total

1.  Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.

Authors:  Letícia S Koester; Clarissa R Xavier; Paulo Mayorga; Valquiria L Bassani
Journal:  Eur J Pharm Biopharm       Date:  2003-01       Impact factor: 5.571

2.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

3.  Interactions between polycyclic aromatic hydrocarbons and dissolved humic material: binding and dissociation.

Authors:  J F McCarthy; B D Jimenez
Journal:  Environ Sci Technol       Date:  1985-11-01       Impact factor: 9.028

Review 4.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  Application of alkaline treatment for sludge decrement and humic acid recovery.

Authors:  Huan Li; Yiying Jin; Yongfeng Nie
Journal:  Bioresour Technol       Date:  2009-08-03       Impact factor: 9.642

6.  Liquid chromatography/tandem mass spectrometry for the determination of carbamazepine and its main metabolite in rat plasma utilizing an automated blood sampling system.

Authors:  Yongxin Zhu; Hwa Chiang; M Wulster-Radcliffe; Rita Hilt; Philip Wong; Candice B Kissinger; Peter T Kissinger
Journal:  J Pharm Biomed Anal       Date:  2005-01-15       Impact factor: 3.935

7.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate.

Authors:  Y Kobayashi; S Ito; S Itai; K Yamamoto
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

8.  Synthesis and anticonvulsant and neurotoxicity evaluation of N4-phthalimido phenyl (thio) semicarbazides.

Authors:  P Yogeeswari; D Sriram; V Saraswat; J Vaigunda Ragavendran; M Mohan Kumar; S Murugesan; R Thirumurugan; J P Stables
Journal:  Eur J Pharm Sci       Date:  2003-11       Impact factor: 4.384

9.  A comparative study of the adsorption of humic acid, fulvic acid and phenol onto Bacillus subtilis and activated sludge.

Authors:  Marco N Moura; María J Martín; Francisco J Burguillo
Journal:  J Hazard Mater       Date:  2007-03-19       Impact factor: 10.588

10.  Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model.

Authors:  Vivek R Yadav; Sarasija Suresh; Kshama Devi; Seema Yadav
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246

View more
  5 in total

1.  Small-molecule fulvic acid with strong hydration ability for non-vitreous cellular cryopreservation.

Authors:  Guoying Bai; Jinhao Hu; Sijia Qin; Zipeng Qi; Hening Zhuang; Fude Sun; Youhua Lu; Shenglin Jin; Dong Gao; Jianjun Wang
Journal:  iScience       Date:  2022-05-18

2.  Quantitative Structure-Activity Relationship, Ontology-Based Model of the Antioxidant and Cell Protective Activity of Peat Humic Acids.

Authors:  Maria V Zykova; Konstantin S Brazovskii; Kristina A Bratishko; Evgeny E Buyko; Lyudmila A Logvinova; Sergey V Romanenko; Andrey I Konstantinov; Sergei V Krivoshchekov; Irina V Perminova; Mikhail V Belousov
Journal:  Polymers (Basel)       Date:  2022-08-12       Impact factor: 4.967

3.  Physicochemical Characterization and Antioxidant Activity of Humic Acids Isolated from Peat of Various Origins.

Authors:  Maria V Zykova; Igor A Schepetkin; Michael V Belousov; Sergey V Krivoshchekov; Lyudmila A Logvinova; Kristina A Bratishko; Mekhman S Yusubov; Sergey V Romanenko; Mark T Quinn
Journal:  Molecules       Date:  2018-03-24       Impact factor: 4.411

Review 4.  Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes.

Authors:  John Winkler; Sanjoy Ghosh
Journal:  J Diabetes Res       Date:  2018-09-10       Impact factor: 4.011

5.  A Use of Tritium-Labeled Peat Fulvic Acids and Polyphenolic Derivatives for Designing Pharmacokinetic Experiments on Mice.

Authors:  Gennady A Badun; Maria G Chernysheva; Yury V Zhernov; Alina S Poroshina; Valery V Smirnov; Sergey E Pigarev; Tatiana A Mikhnevich; Dmitry S Volkov; Irina V Perminova; Elena I Fedoros
Journal:  Biomedicines       Date:  2021-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.